Impdh Inhibition Activates Tlr-VCAM1 Pathway and Suppresses the Development of Mll-Fusion Leukemia

The authors found that AMLs with MLL-fusions were susceptible to Inosine monophosphate dehydrogenase inhibitors in vitro.